Liver and Spleen Imaging

A liver scan can detect cancer, hepatitis, and cirrhosis, as well as tumors, abscesses, cysts, hematomas, liver enlargement, and injuries to the nearby spleen. It may be repeated to track the progression of an existing disease and/or the effectiveness of any treatments.

Because the radioactive substance used is small and only active for a short period of time, it is considered safe for the vast majority of patients. Typically, the body eliminates the substance after 24 hours. It is not recommended for pregnant or nursing mothers.

• After the liver, spleen, and bone marrow's reticuloendothelial cells have quickly phagocytized a 9 9 mTc-labeled colloid, liver-spleen imaging is carried out.
• Hepatic cavernous haemangiomas are identified via liver blood pool imaging after the injection of 9 9 mTc-labeled red blood cells.
• To assess the effectiveness of intra-arterially administered drugs, hepatic perfusion tests are carried out after the injection of 99mTc-macro aggregated albumin (MAA) through a hepatic artery catheter.
• Splenic imaging is carried out following the injection of 9 9 mTc-labeled red blood cells that have been heat-damaged.
• Working splenic tissue takes up damaged red blood cells in a selective manner.